drugset / Trial / NCT06191042

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

NCT06191042 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The main objective of this study is to investigate the safety and tolerability of si-544. Other objectives are to study the metabolism of si-544 in the body and to assess the effects of si-544 on cells of the body's immune system (immune cells) that have been chronically activated by the disease. Likewise, the effect of si-544 on inflammatory responses in the body triggered by the disease and other disease symptoms will be investigated.

Timeline

Start
2024-01-22
Primary completion
2025-06-23
Completion
2025-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject si-544 Unknown — Subcutaneous